Calimaran Arthur L, Strauss-Hoder Tina P, Wang Warren Y, McCarthy Robert J, Wong Cynthia A
Department of Anesthesiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Anesth Analg. 2003 Apr;96(4):1167-1172. doi: 10.1213/01.ANE.0000054204.11293.3C.
Labor analgesia initiated with intrathecal bupivacaine and fentanyl, without a local anesthetic epidural test dose, provides effective analgesia and allows ambulation. In this study, we sought to determine the effect of a lidocaine-epinephrine test dose administered immediately after the initiation of combined spinal-epidural (CSE) analgesia with bupivacaine 2.5 mg and fentanyl 25 micro g on parturients' hemodynamic stability, posterior column function, motor strength, and subjective ability to walk. Parturients (n = 153) were randomized to receive either 3 mL of epidural saline or lidocaine 1.5% with epinephrine 1:200,000. Hemodynamic variables, proprioception, straight leg raise, and the modified Bromage score were analyzed in 110 parturients who completed the study protocol and were not different between groups. Vibratory sense, the ability to perform a partial deep knee bend and to step up on a stool, and the subjective ability to walk were impaired in a larger number of parturients in the lidocaine-epinephrine group at 30 min (P < 0.05). At 60 min, there were no differences between the groups except that fewer parturients in the lidocaine-epinephrine group could step up on a stool. The straight leg raise against resistance and the modified Bromage scale did not correlate well with other tests of motor strength (Spearman's rho, 0.273-0.405). These data suggest that the test dose should be avoided immediately after initiation of CSE analgesia when early ambulation is desired.
A lidocaine-epinephrine epidural test dose (3 mL of lidocaine 1.5% with epinephrine 1:200,000), injected immediately after the initiation of combined spinal-epidural labor analgesia with bupivacaine 2.5 mg and fentanyl 25 microg, may interfere with the ability to perform simple tests of motor function and ambulation.
鞘内注射布比卡因和芬太尼启动分娩镇痛,不使用局部麻醉硬膜外试验剂量,可提供有效的镇痛并允许产妇行走。在本研究中,我们试图确定在使用2.5mg布比卡因和25μg芬太尼进行腰麻-硬膜外联合(CSE)镇痛开始后立即给予利多卡因-肾上腺素试验剂量对产妇血流动力学稳定性、后柱功能、肌力和主观行走能力的影响。将153例产妇随机分为两组,分别接受3mL硬膜外生理盐水或含1:200,000肾上腺素的1.5%利多卡因。对110例完成研究方案且两组间无差异的产妇进行血流动力学变量、本体感觉、直腿抬高和改良Bromage评分分析。利多卡因-肾上腺素组在30分钟时,更多产妇的振动觉、进行部分深屈膝和踏上凳子的能力以及主观行走能力受损(P<0.05)。在60分钟时,除利多卡因-肾上腺素组中较少产妇能踏上凳子外,两组间无差异。抗阻力直腿抬高和改良Bromage量表与其他肌力测试的相关性不佳(Spearman秩相关系数,0.273 - 0.405)。这些数据表明,当期望早期行走时,CSE镇痛开始后应避免立即给予试验剂量。
在使用2.5mg布比卡因和25μg芬太尼进行腰麻-硬膜外联合分娩镇痛开始后立即注射含1:200,000肾上腺素的1.5%利多卡因硬膜外试验剂量(3mL),可能会干扰进行简单运动功能测试和行走的能力。